title: ACR appropriateness criteria®nasal cavity and paranasal sinus cancers.
abstract: The American College of Radiology (ACR) Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. Here, we present the Appropriateness Criteria for cancers arising in the nasal cavity and paranasal sinuses (maxillary, sphenoid, and ethmoid sinuses). This includes clinical presentation, prognostic factors, principles of management, and treatment outcomes. Controversies regarding management of cervical lymph nodes are discussed. Rare and unusual nasal cavity cancers, such as esthesioneuroblastoma and sinonasal undifferentiated carcinomas, are included. © 2016 American College of Radiology. Head Neck, 2016 © 2016 Wiley Periodicals, Inc. Head Neck 39: 407-418, 2017.
authors.affiliation: Henry Ford Health System, Detroit, Michigan.
authors.forename: Farzan
authors.initials: F
authors.lastname: Siddiqui
authors.affiliation: Montefiore Medical Center, American College of Surgeons, Bronx, New York.
authors.forename: Richard V
authors.initials: RV
authors.lastname: Smith
authors.affiliation: University of California San Francisco, San Francisco, California.
authors.forename: Sue S
authors.identifier: 0000-0002-0779-7476
authors.initials: SS
authors.lastname: Yom
authors.affiliation: Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Jonathan J
authors.initials: JJ
authors.lastname: Beitler
authors.affiliation: Massachusetts General Hospital, Boston, Massachusetts.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Busse
authors.affiliation: Maimonides Cancer Center, Brooklyn, New York.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Cooper
authors.affiliation: University of Texas MD Anderson Cancer Center, Houston, Texas.
authors.forename: Ehab Y
authors.identifier: 0000-0003-3241-2440
authors.initials: EY
authors.lastname: Hanna
authors.affiliation: Radiological Associates of Sacramento, Sacramento, California.
authors.forename: Christopher U
authors.initials: CU
authors.lastname: Jones
authors.affiliation: Cleveland Clinic, Cleveland, Ohio.
authors.forename: Shlomo A
authors.initials: SA
authors.lastname: Koyfman
authors.affiliation: Johns Hopkins University, Baltimore, Maryland.
authors.forename: Harry
authors.initials: H
authors.lastname: Quon
authors.affiliation: Fox Chase Cancer Center, American College of Surgeons, Philadelphia, Pennsylvania.
authors.forename: John A
authors.initials: JA
authors.lastname: Ridge
authors.affiliation: Emory University, American Society of Clinical Oncology, Atlanta, Georgia.
authors.forename: Nabil F
authors.initials: NF
authors.lastname: Saba
authors.affiliation: University of Michigan, American Society of Clinical Oncology, Ann Arbor, Michigan.
authors.forename: Francis
authors.initials: F
authors.lastname: Worden
authors.affiliation: University Hospitals Case Medical Center, Cleveland, Ohio.
authors.forename: Min
authors.initials: M
authors.lastname: Yao
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Joseph K
authors.initials: JK
authors.lastname: Salama
mesh_terms: D059186:Chemoradiotherapy, Adjuvant / Q000379:methods*; D003131:Combined Modality Therapy / Q000379:methods; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D009296:Nasal Cavity / Q000473:pathology*; D059747:Nasal Surgical Procedures / Q000379:methods*; D009669:Nose Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D010255:Paranasal Sinus Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D018570:Risk Assessment; D012955:Societies, Medical; D016019:Survival Analysis; D016896:Treatment Outcome
keywords: Appropriateness Criteria; esthesioneuroblastoma; nasal cavity cancer; paranasal sinus cancer; sinonasal undifferentiated carcinoma